| Literature DB >> 33241114 |
Branavan Manoranjan1, Ashley A Adile2, Chitra Venugopal3, Sheila K Singh2,3.
Abstract
Medulloblastoma (MB) represents the most common malignant pediatric brain tumor and is defined by four molecular subgroups with WNT MB having the most favorable prognosis. Our work provides a rational therapeutic option in which the protective effects of WNT-driven MBs may be augmented in Group 3 and 4 MB.Entities:
Keywords: Medulloblastoma; WNT; beta-catenin; brain tumor-initiating cell
Year: 2020 PMID: 33241114 PMCID: PMC7671060 DOI: 10.1080/23723556.2020.1834903
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556